These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 16809887

  • 1. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
    Takenokuchi M, Saigo K, Nakamachi Y, Kawano S, Hashimoto M, Fujioka T, Koizumi T, Tatsumi E, Kumagai S.
    Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 3. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH.
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E.
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [Abstract] [Full Text] [Related]

  • 5. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC.
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [Abstract] [Full Text] [Related]

  • 6. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG.
    J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072
    [Abstract] [Full Text] [Related]

  • 7. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y.
    Cancer Res; 2000 Oct 01; 60(19):5558-64. PubMed ID: 11034103
    [Abstract] [Full Text] [Related]

  • 8. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Higuchi K, Arakawa T.
    Oncol Rep; 2005 Apr 01; 13(4):601-6. PubMed ID: 15756430
    [Abstract] [Full Text] [Related]

  • 9. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D, Yoshida K, Tanabe K, Hihara J, Toge T.
    Anticancer Res; 2004 Apr 01; 24(3a):1409-16. PubMed ID: 15274302
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M, Lee TW, Yim AP, Mok TS, Chen GG.
    J Cell Physiol; 2006 Nov 01; 209(2):428-38. PubMed ID: 16883598
    [Abstract] [Full Text] [Related]

  • 11. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May 01; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 12. PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.
    Chaffer CL, Thomas DM, Thompson EW, Williams ED.
    BMC Cancer; 2006 Mar 06; 6():53. PubMed ID: 16519808
    [Abstract] [Full Text] [Related]

  • 13. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
    Zhu H, Pan X, Qi H, Wang X, Hou S, Han B, Liu Z, Xu L.
    Oncol Rep; 2011 Jan 06; 25(1):81-90. PubMed ID: 21109961
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K.
    Cancer; 2002 Nov 15; 95(10):2243-51. PubMed ID: 12412180
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW.
    Ann Hematol; 2007 Mar 15; 86(3):173-83. PubMed ID: 17089125
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma.
    Fujita M, Yagami T, Fujio M, Tohji C, Takase K, Yamamoto Y, Sawada K, Yamamori M, Okamura N.
    Cancer Lett; 2011 Dec 22; 312(2):219-27. PubMed ID: 21903322
    [Abstract] [Full Text] [Related]

  • 17. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
    Koirala K, Wan YL, Liu YC, Wang X, Cui W, Wang CL, Chen HN, Wang HY, Zhu J.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug 18; 38(4):385-8. PubMed ID: 16892143
    [Abstract] [Full Text] [Related]

  • 18. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T.
    J Clin Endocrinol Metab; 2001 May 18; 86(5):2170-7. PubMed ID: 11344222
    [Abstract] [Full Text] [Related]

  • 19. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S, Koeffler HP.
    Cancer Res; 2000 Oct 01; 60(19):5494-8. PubMed ID: 11034093
    [Abstract] [Full Text] [Related]

  • 20. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J, Flament S, Salamone S, Boisbrun M, Mazerbourg S, Chapleur Y, Grillier-Vuissoz I.
    Breast Cancer Res Treat; 2008 Dec 01; 112(3):437-51. PubMed ID: 18204896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.